Researchers have been excited about Retatrutide , a groundbreaking dual agonist showing promising data in initial trials for size reduction . It functions by impacting several systems: GLP-1 and GIP, these, when engaged , assist control cravings and improve metabolism . Preliminary reports demonstrate noteworthy size loss and possible benefits for